SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458509106851v1
15/10/1153    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fazio, R.
Right arrow Articles by Martino, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fazio, R.
Right arrow Articles by Martino, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients

R. Fazio

Institute of Experimental Neurology (INSpe), Department of Neurology, San Raffaele Scientific Institute, Milan, Italy

ML Malosio

Immunology of Diabetes Unit, San Raffaele Scientific Institute, Milan, Italy

V. Lampasona

Human Molecular Genetics Unit, San Raffaele Scientific Institute, Milan, Italy

D. De Feo

Institute of Experimental Neurology (INSpe), Department of Neurology, San Raffaele Scientific Institute, Milan, Italy

D. Privitera

Institute of Experimental Neurology (INSpe), Department of Neurology, San Raffaele Scientific Institute, Milan, Italy

F. Marnetto

Centro di Riferimento Regionale Sclerosi Multipla (CReSM) and Neurobiologia Clinica, ASO S. Luigi Gonzaga, Orbassano, Turin, Italy

D. Centonze

Clinica Neurologica, Dipartimento di Neuroscienze, Università Tor Vergata, Rome, Italy

A. Ghezzi

Ospedale di Gallarate, Centro Studi Sclerosi Multipla, Gallarate, Varese, Italy

G. Comi

Institute of Experimental Neurology (INSpe), Department of Neurology, San Raffaele Scientific Institute, Milan, Italy

R. Furlan

Institute of Experimental Neurology (INSpe), Department of Neurology, San Raffaele Scientific Institute, Milan, Italy, furlan.roberto{at}hsr.it

G. Martino

Institute of Experimental Neurology (INSpe), Department of Neurology, San Raffaele Scientific Institute, Milan, Italy

Background: Antibodies against aquaporin-4 (AQP4), a water channel particularly expressed on perivascular astrocytic podocytes, are proposed as a marker for the diagnosis of neuromyelitis optica (NMO). However, a consensus on seroprevalence and optimal detection method has not yet been reached.

Objectives: To investigate the performance of different assays to detect anti-AQP4 antibodies.

Methods: We set up five different assays. Two of them were capable to detect perivascular IgG reactivity on brain tissue by immunofluorescence (NMO-IgG). Other three assays have been set to detect anti-AQP4 antibodies: immunofluorescence and flow cytometry on AQP4-expressing cells, and a radioimmunoprecipitation assay. We assessed sensitivity and specificity of these assays by interrogating sera of 33 NMO patients, 13 patients at high risk to develop NMO (hrNMO), 6 patients affected by acute partial transverse myelitis (APTM), 20 patients with multiple sclerosis (MS), and 67 age- and sex-matched healthy controls.

Results: We found that the presence of serum NMO-IgG and anti-AQP4 reactivity is almost exclusively restricted to patients with NMO and hrNMO. Seroprevalence and sensitivity ranged from 30 to 47%, depending on the assay. Specificity ranged from 95 to 100%. Comparing results obtained in the five assays, we noticed lack of concordance in some samples.

Conclusions: Detection of NMO-IgG or anti-AQP4 antibodies may represent a valuable tool to assist neurologists in the differential diagnosis between patients with NMO, hrNMO, APTM, or MS. The current lack of a gold standard to detect anti-AQP4 antibodies implies the necessity to standardize the detection of these antibodies.

Key Words: Neuromyelitis optica

This version was published on October 1, 2009

Multiple Sclerosis, Vol. 15, No. 10, 1153-1163 (2009)
DOI: 10.1177/1352458509106851


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement